Extracellular matrix proteins, including fibronectin (FN), provide an important means for modulating of cell function. During inflammation and wound healing, plasma FN (pFN) extravasates and is incorporated into fibrin gels that are thought to serve as a provisional matrix for the migration of a variety of inflammatory cells as well as keratinocytes and fibroblasts. When tested in culture, pFN modulates certain functions of mononuclear phagocytes, including, phagocytosis, migration, synthesis and secretion. This adhesive glycoprotein is synthesized by macrophages and also enhances certain activities of these cells. Fibronectin is not a single protein but comprises a group of closely related glycoproteins which arise by alternative splicing within a single gene transcript. It is now clear that different cells secrete different forms of fibronectin, however the structure of fibronectins produced by macrophages is unknown. This proposal is concerned with elucidating the structure and function of fibronectins produced by macrophages during inflammation. Preliminary evidence, obtained by in situ hybridization with domain-specific fibronectin probes, indicates that these cells modulate the forms of fibronectin produced during wound healing. Experiments are proposed, utilizing this methodology, as well as RNA mapping and immunocytochemistry, to determine if macrophages in delayed hypersensitivity reactions and granulomas also express alternatively spliced forms of fibronectin. These data provide the basis for experiments, using recombinant fibronectins, to determine if spliced domains within this protein alter specific macrophage functions. A third part of this study proposes experiments to establish culture conditions which modulate fibronectin synthesis and alternative splicing patterns. These experiments are expected to provide new insights into the functions of specific domains within fibronectin, the role that alternatively spliced forms of fibronectin and macrophages play during inflammation, and may ultimately provide the basis for therapeutic modulation of macrophage function during wound healing.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM036812-06
Application #
3291332
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1986-12-01
Project End
1993-11-30
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Kubo, M; Van de Water, L; Plantefaber, L C et al. (2001) Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol 117:1369-81
Coito, A J; Korom, S; Graser, E et al. (1998) Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine Transplantation 65:699-706
Coito, A J; Brown, L F; Peters, J H et al. (1997) Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts. Am J Pathol 150:1757-72
Van de Water, L (1997) Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease. J Urol 157:306-10
Coito, A J; Korom, S; Van de Water, L et al. (1997) Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipients. Transplant Proc 29:1060-1
Brown, L F; Olbricht, S M; Berse, B et al. (1995) Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154:2801-7
Detmar, M; Yeo, K T; Nagy, J A et al. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50
Dubin, D; Peters, J H; Brown, L F et al. (1995) Balloon catheterization induced arterial expression of embryonic fibronectins. Arterioscler Thromb Vasc Biol 15:1958-67
Coito, A J; Binder, J; Brown, L F et al. (1995) TNF-alpha upregulates the expression of fibronectin in acutely rejecting rat cardiac allografts. Transplant Proc 27:463-5
Coito, A J; Binder, J; Brown, L F et al. (1995) Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats. J Immunol 154:2949-58

Showing the most recent 10 out of 16 publications